Dr. Yannuzzi has made numerous innovative and lasting contributions in imaging, drug development, and therapeutic modalities. He was the first to use oral non-steroid anti-inflammatory medication for the treatment of cystoid macular edema and developed an eye drop to treat this condition. He has described new diseases as well as new associations and manifestations of established entities and photosensitization.He has published over 400 scientific papers and 13 books, which have earned him respect and admiration in the ophthalmic-retinal community and retina specialists internationally. He is well recognized as a devoted and excellent educator, a superb clinical diagnostician, and a prolific organizer of retinal meetings worldwide. Dr. Yannuzzi is rated as a Distinguished provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Adult-Onset Vitelliform Macular Dystrophy (AVMD), and Vitrectomy.

Dr. Cooney is a practicing vitreoretinal surgeon who was previously an assistant professor of ophthalmology at Johns Hopkins University and later became the director of the Medical Retina Service, the Duke Center for Macular Degeneration, and the medical retina fellowship program from 2001 to 2005. He received a MBA degree from Kenan-Flagler Business School at the University of North Carolina, Chapel Hill.Dr. Cooney serves as a consultant and advisory board member for several pharmaceutical companies. In 1998, Dr. Cooney helped to establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics and served as a consultant from 2000 to 2002.Dr. Cooney’s clinical practice focuses on the medical and surgical treatment of vitreoretinal diseases, particularly age-related macular degeneration and diabetic retinopathy. He is actively involved in the clinical development of new diagnostic and therapeutic modalities for vitreoretinal disease and the training of residents and fellows.,Dr. Cooney helped establish InnoRx, an ophthalmic drug delivery and pharmaceutical company acquired by SurModics. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Cone Dystrophy, and Usher Syndrome.

Dr. Spaide specializes in diseases of the retina and vitreous. His particular interests include retinal surgery, Macular Degeneration, Macular Holes, Macular Pucker, Diabetic Retinopathy, and intraocular inflammation. He has published more than 300 articles and 50 book chapters and 9 books about the diagnosis and treatment of Retinal Diseases. He has given lectures around the world.He has a remarkable number of “firsts” in retinal diseases including the development of autofluorescence imaging using a fundus camera and the first practical method to image deeper structures in the eye with optical coherence tomography. These imaging methods now are used around the world. He has described many new findings and diseases of the eye and helped develop many novel treatments. He has developed numerous surgical instruments that were named after him and holds patents for ophthalmic inventions.He is the recipient of the Richard and Hilda Rosenthal Foundation Award in the Visual Sciences, the Senior Honor Award from the American Society of Retinal Surgeons, and the Senior Achievement Award from the American Academy of Opthalmology and the Prix Soubrane de la Recherche en Ophthalmologie, Award of Merit from the Retina Society, the Henkind Award, Coscas Award, Nataraja Pillai Award, W. Richard Green MD Award, George Theodossiadis Award, Founders Award, American Society of Retinal Surgeons, Life Achievement Honor Award, and the American Academy of Ophthalmology. Dr. Spaide is rated as a Distinguished provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Age-Related Macular Degeneration (ARMD), Late-Onset Retinal Degeneration, Geographic Atrophy, Central Serous Chorioretinopathy, and Vitrectomy.

Philip Ferrone is an Ophthalmologist in Elmhurst, New York. Dr. Ferrone is rated as a Distinguished provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Coats Disease, and Vitrectomy.

Wayne Fuchs is an Ophthalmologist in New York, New York. Dr. Fuchs has been practicing medicine for over 47 years and is rated as an Experienced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Central Serous Chorioretinopathy, and Retinal Vein Occlusion.

Susan Fromer is an Ophthalmologist in New York, New York. Dr. Fromer is rated as an Experienced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Glaucoma, Kallikrein Hypertension, Allergic Conjunctivitis, and Meibomianitis.

Talia Kaden is a General Surgeon and an Ophthalmologist in New York, New York. Dr. Kaden is rated as an Experienced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Retinal Detachment, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), Vitrectomy, and Iridectomy.

Naomi Goldberg is an Ophthalmologist in New York, New York. Dr. Goldberg is rated as an Experienced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Uveitis, Birdshot Chorioretinopathy, Scleritis, and Neuroretinitis.

Andrew Naing is an Ophthalmologist in New York, New York. Dr. Naing is rated as an Experienced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Glaucoma, Eyelid Bump, Meibomianitis, and Age-Related Macular Degeneration (ARMD).

Golnaz Moazami is an Ophthalmologist in New York, New York. Dr. Moazami is rated as an Experienced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Optic Atrophy Type 1, Optic Nerve Atrophy, Ocular Hypertension (OHT), and Fourth Cranial Nerve Palsy.

David Abramson is an Ophthalmologist in New York, New York. Dr. Abramson is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Retinoblastoma, Hereditary Retinoblastoma, Melanoma of the Eye, Vitrectomy, and Leg or Foot Amputation.

Jerome Giovinazzo is an Ophthalmologist in Staten Island, New York. Dr. Giovinazzo is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Cataract, Kallikrein Hypertension, Retinal Vasculopathy with Cerebral Leukodystrophy, Vitrectomy, and Colonoscopy.

Nancy Tsai is an Ophthalmologist in New York, New York. Dr. Tsai is rated as an Advanced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Meibomianitis, Optic Nerve Atrophy, Optic Atrophy Type 1, and Parinaud Oculoglandular Syndrome. Dr. Tsai is currently accepting new patients.

Raphael Castillo is an Ophthalmologist in New York, New York. Dr. Castillo is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Coats Disease, Familial Exudative Vitreoretinopathy, Retinal Vasculopathy with Cerebral Leukodystrophy, and Optic Atrophy Type 1. Dr. Castillo is currently accepting new patients.

Keith Chang is an Ophthalmologist in New York, New York. Dr. Chang is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Blepharitis, Dry Eye Syndrome, Allergic Conjunctivitis, and Conjunctivitis (Pink Eye).

Alexander Rabinovich is an Ophthalmologist in New York, New York. Dr. Rabinovich is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Meibomianitis, Chalazion, Eyelid Bump, and Eyelid Drooping. Dr. Rabinovich is currently accepting new patients.

Andrew Gewirtz is an Ophthalmologist in New York, New York. Dr. Gewirtz is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Meibomianitis, Choroid Plexus Carcinoma, Entropion, and Glaucoma. Dr. Gewirtz is currently accepting new patients.

Anthony Curreri is an Ophthalmologist in New York, New York. Dr. Curreri is rated as an Advanced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Ocular Hypertension (OHT), Conjunctivitis (Pink Eye), Glaucoma, and Pinguecula. Dr. Curreri is currently accepting new patients.

Dr. Klancnik utilizes all forms of ophthalmic imaging including fluorescein angiography, indocyanine green angiography, as well as noninvasive forms of imaging such as spectral domain optical coherence tomography, autofluorescence photography, and ultrasonography.Dr. Klancnik is a magna cum laude graduate of Yale University. He earned his medical degree from Jefferson Medical College of Thomas Jefferson University and was elected to the Alpha Omega Alpha and Hobart Amory Hare honor medical societies. He completed his internship at the Lankenau Hospital and his ophthalmology residency at Wills Eye Hospital. He completed his medical and surgical vitreoretinal fellowship at Manhattan Eye, Ear & Throat Hospital and Columbia University. He is an Assistant Professor of Clinical Ophthalmology at New York University School of Medicine.Dr. Klancnik is a member of numerous medical organizations including the American Academy of Ophthalmology, American Society of Retinal Specialists, and Association for Research in Vision and Ophthalmology. He is an author of numerous peer-reviewed journal articles and book chapters and has presented at scientific meetings nationally and internationally. He is active in numerous clinical trials as principle or sub-investigator and serves as a reviewer for several ophthalmology journals. Dr. Klancnik is rated as an Experienced provider by MediFind in the treatment of Coats Disease. His top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Retinal Vein Occlusion.

Irene A. Barbazetto, M.D. is a vitreoretinal surgeon and macular disease specialist board certified in the United States and Europe. She is an internationally recognized expert in the treatment of macular degeneration, retinal vascular disease, retinal vein occlusion, hereditary retinal disease, and diabetes.The author of more than 40 peer-reviewed articles and book chapters, she serves on the Editorial Board of the prestigious journal Graefe’s Archive of Clinical and Experimental Ophthalmology. Dr. Barbazetto is the recipient of the 2009 Achievement Award from the American Academy of Ophthalmology. Her patients voted her as one of the best retina doctors, America’s “Most Compassionate Physicians,” and she received the “Patient’s Choice Award” in 2010. A graduate of Hamburg University, Germany, Dr. Barbazetto’s doctoral thesis investigated a newly developed vision-screening test (H-Test) for pre-school children and was awarded cum laude. She completed her ophthalmology residency in Lübeck, Germany, where she participated in the development of photodynamic therapy for the treatment of macular degeneration.In 2000, she came to New York for a research fellowship with Dr. Stanley Chang at Columbia University, focusing on the role of oxygen in the development of cataract after vitreoretinal surgery. She completed an internship in general surgery at the Lenox Hill Hospital in Manhattan and an ophthalmology residency at Columbia University. Dr. Barbazetto is rated as an Experienced provider by MediFind in the treatment of Coats Disease. Her top areas of expertise are Central Serous Chorioretinopathy, Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Adult-Onset Vitelliform Macular Dystrophy (AVMD).